YPHDF (Ypsomed Holding AG) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YPHDF Ypsomed Holding AG YPHDF
94 GF Score
Price $476.49
GF Value $461.36
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Net Loan?

Net Loan only applies to banks and insurance companies.

YPHDF
94GF Score
Ypsomed Holding AG YPHDF
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ypsomed Holding AG (YPHDF) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be overvalued. The current stock price of $476.49 is trading 3.3% above its estimated GF Value™ of $461.36. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for YPHDF:

  • Net Loan:
  • GF Value™: $461.36 vs. price of $476.49 (3.3% above fair value)
  • GF Score™: 94/100 with 5 warning signs

No single metric tells the full story. See the YPHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
94GF Score

Get the complete analysis for YPHDF

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$476.49
Price
$461.36
GF Value